J. Mihura

459 total citations
15 papers, 344 citations indexed

About

J. Mihura is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, J. Mihura has authored 15 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in J. Mihura's work include Neutropenia and Cancer Infections (4 papers), Breast Cancer Treatment Studies (4 papers) and Cancer Treatment and Pharmacology (3 papers). J. Mihura is often cited by papers focused on Neutropenia and Cancer Infections (4 papers), Breast Cancer Treatment Studies (4 papers) and Cancer Treatment and Pharmacology (3 papers). J. Mihura collaborates with scholars based in France and Germany. J. Mihura's co-authors include B. De Lafontan, Pierre Kerbrat, S Schraub, T Palangié, Véronique Mosseri, Philippe Rouanet, Thierry Dorval, Philippe Beuzeboc, P. Fumoleau and P. Fargeot and has published in prestigious journals such as Journal of Clinical Oncology, Radiology and British Journal of Cancer.

In The Last Decade

J. Mihura

15 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Mihura France 9 216 166 88 66 52 15 344
María Jesús Quintana Spain 10 205 0.9× 113 0.7× 120 1.4× 29 0.4× 50 1.0× 11 424
Alexandra Tsigginou Greece 12 211 1.0× 110 0.7× 49 0.6× 30 0.5× 93 1.8× 19 366
Amna Sheri United Kingdom 9 200 0.9× 147 0.9× 66 0.8× 22 0.3× 61 1.2× 20 306
Carol S. Connor United States 10 284 1.3× 234 1.4× 104 1.2× 108 1.6× 118 2.3× 24 469
S A Bartow United States 7 166 0.8× 106 0.6× 62 0.7× 181 2.7× 88 1.7× 8 416
Rodrigo Gonçalves Brazil 11 136 0.6× 190 1.1× 74 0.8× 57 0.9× 67 1.3× 29 321
Antonia Márquez Spain 10 294 1.4× 134 0.8× 50 0.6× 24 0.4× 107 2.1× 15 444
Maggie Wilcox United Kingdom 6 340 1.6× 304 1.8× 83 0.9× 51 0.8× 65 1.3× 9 512
Katalin Ormándi Hungary 11 123 0.6× 153 0.9× 118 1.3× 19 0.3× 26 0.5× 26 262
Audun Braaten Norway 6 230 1.1× 247 1.5× 83 0.9× 44 0.7× 242 4.7× 8 530

Countries citing papers authored by J. Mihura

Since Specialization
Citations

This map shows the geographic impact of J. Mihura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Mihura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Mihura more than expected).

Fields of papers citing papers by J. Mihura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Mihura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Mihura. The network helps show where J. Mihura may publish in the future.

Co-authorship network of co-authors of J. Mihura

This figure shows the co-authorship network connecting the top 25 collaborators of J. Mihura. A scholar is included among the top collaborators of J. Mihura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Mihura. J. Mihura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Martel, P., et al.. (2000). [Cervical adenocarcinomas: diagnostic, prognostic and therapeutic aspects in a 49 case-control study].. PubMed. 29(1). 48–54. 4 indexed citations
3.
Gladieff, Laurence, Étienne Chatelut, M Gaspard, et al.. (1999). [Intraperitoneal high dose chemotherapy as consolidation treatment for advanced ovarian carcinoma: a pilot study].. PubMed. 86(7-8). 673–7. 4 indexed citations
4.
Chevreau, Christine, Binh Bui, Bernard Chevallier, et al.. (1999). Phase I-II Trial of Intensification of the MAID Regimen With Support of Lenograstim (rHuG-CSF) in Patients With Advanced Soft-Tissue Sarcoma (STS). American Journal of Clinical Oncology. 22(3). 267–272. 9 indexed citations
5.
Auvergnat, J.Ch., et al.. (1998). Low-Dose Splenic Irradiation in the Treatment of Immune Thrombocytopenia in HIV-Infected Patients. International Journal of Radiation Oncology*Biology*Physics. 41(1). 123–126. 8 indexed citations
6.
7.
Bachaud, Jean‐Marc, M. Murris‐Espin, C. Hermant, et al.. (1998). Relation between unbound plasma concentrations and toxicity in a prolonged oral etoposide schedule. European Journal of Clinical Pharmacology. 54(9-10). 677–683. 18 indexed citations
8.
Barthélémy, Isabelle, et al.. (1997). [Results of the surgical treatment of epidermoid carcinoma of the mobile tongue and mouth floor. Apropos of 157 patients].. PubMed. 98(5). 306–11. 1 indexed citations
9.
Toulas, Christine, J. Mihura, Christine de Balincourt, et al.. (1996). Potential prognostic value in human breast cancer of cytosolic Nme1 protein detection using an original hen specific antibody. British Journal of Cancer. 73(5). 630–635. 14 indexed citations
11.
Gladieff, Laurence, et al.. (1996). [A phase II study with mitoxantrone-vinorelbine association in the treatment of advanced breast cancer in elderly women].. PubMed. 83(9). 703–6. 4 indexed citations
13.
Palangié, T, Véronique Mosseri, J. Mihura, et al.. (1994). Prognostic factors in inflammatory breast cancer and therapeutic implications. European Journal of Cancer. 30(7). 921–927. 70 indexed citations
14.
Lafontan, B. De, et al.. (1994). Isolated clustered microcalcifications: diagnostic value of mammography--series of 400 cases with surgical verification.. Radiology. 190(2). 479–483. 54 indexed citations
15.
Fumoleau, P., Yves Devaux, Pierre Kerbrat, et al.. (1993). Premenopausal Patients with Node-Positive Resectable Breast Cancer. Drugs. 45(Supplement 2). 38–45. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026